| Novartis Pharma Schweiz AG - Kesimpta, Injektionslösung in Fertigpen |
| 67758 | | 01 | | Kesimpta | | Injektionslösung in Fertigpen | | L04AA52 | | Ofatumumab | | 01.02.2021 | | |
|
| Composition |
| ofatumumabum 20 mg, argininum, natrii acetas trihydricus, natrii chloridum, polysorbatum 80, dinatrii edetas, acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.92 mg. |
| Packungsbestandteile |
| Injektionslösung in Fertigpen | | | | | | | | Active Agent | Dose |
|---|
| Ofatumumabum | 20mg / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Ofatumumabum | 20 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | 25 | | Arginine | | | Dinatrii Edetas | | | Sodium Acetate Trihydrate | | | Sodium Chloride | | | Per Centum | | | Polysorbatum 80 | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1139.39 | 1255.55 | B | SL | Yes |
|
